F2g

Developer of therapeutic treatments for rare and life threatening infections

placeManchester, England, United Kingdom calendar_todayFounded 1998 groups27 employees language f2g.com

Registered entities

Social engagement

Social engagement: 8K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

23 investors on record; lead investors include Morningside, Astellas Venture Management, BankInvest, Advent Life Sciences; 1 has since exited.

Investor typeCountShare
Venture capital1043%
Private equity417%
Bank & private debt29%
Other / undisclosed730%

Recent activity

25 Jun 2026
Event
BIO International Convention
22 Jun 2026
Event
Will Fungi Be the Last of Us? Reviving Infectious Disease Innovation
16 Jun 2026
Event
BIO2026
Coming soon